Implantable cardioverter-defibrillators (ICDs)

The Mayo Clinic Diet Book, learn more

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Risks

By Mayo Clinic staff

Heart-Healthy Living

Subscribe to our Heart-Healthy Living e-newsletter to stay up to date on heart-health topics.

Sign up now

The procedure to implant an ICD has some risks, but they are rare. Risks of the procedure to implant an ICD include:

  • Infection at the site where your ICD was implanted
  • Allergic reaction to the medications used during the procedure to implant your ICD
  • Swelling, bleeding or bruising where your ICD was implanted
  • Damage to the vein where your ICD leads are placed
  • Bleeding around your heart, which can be life-threatening
  • Blood leaking through the heart valve where the ICD lead is placed
References
  1. Implantable cardioverter defibrillator. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/dci/Diseases/icd/icd_all.html. Accessed Aug. 25, 2010.
  2. Epstein AE, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation. 2008;117:e350.
  3. Arnsdorf MF, et al. Role of implantable cardioverter-defibrillator for the secondary prevention of sudden cardiac death. http://www.uptodate.com/home/index.html. Accessed Aug. 25, 2010.
  4. Eckstein J, et al. Necessity for surgical revision of defibrillator leads implanted long-term: Causes and management. Circulation. 2008;117:2727.
  5. Kleemann T, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007;115:2474.
  6. Epstein AE, et al. Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations: A medical/scientific statement from the American Heart Association and North American Society of Pacing and Electrophysiology." Circulation. 2007;115:1170.
  7. Vijgen J, et al. Consensus statement of the European Heart Rhythm Association: Updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace. 2009;11:1097.
  8. Lampert R, et al. HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7:1008..
MY00336 Nov. 19, 2010

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger